Add-On Buprenorphine for Methamphetamine Use Disorder

Topics: Buprenorphine | Methamphetamines | Stimulant use disorder

REVIEW OF: Kheirabadi GR et al, J Clin Psychopharmacol 2021;41(1):45–48 STUDY TYPE: Randomized controlled trial Methamphetamine (meth) addiction is notoriously difficult to treat. There are no FDA-approved medications, and even the most promising trials have mixed results. People withdrawing from meth experience dysphoria, anxiety, mood instabil

Antipsychotics for Methamphetamine Psychosis

Topics: Antipsychotic | Meta-analysis | Methamphetamines | Psychosis

REVIEW OF: Srisurapanont M et al, Drug Alcohol Depend 2021;219:108467 STUDY TYPE: Systematic review and network meta-analysis Methamphetamine psychosis (MAP) is difficult to treat, and there are only so many antipsychotics in our repertoire. Randomized clinical trials (RCTs) to manage MAP are few and far between, and the literature thus far has in